Results 161 to 170 of about 1,359 (188)

Amantadine/droxidopa

Reactions weekly, 2023

semanticscholar   +1 more source

[Study on the metabolism of droxidopa in humans].

Rinsho shinkeigaku = Clinical neurology, 1995
Supplement of the deficient neurotransmitters is one of the most effective therapies for neurodegenerative disorders. For the treatment of Parkinson's disease, L-DOPA therapy has been applied to replace dopamine, and droxidopa (L-threo-3,4-dihydroxyphenylserine) therapy to supply noradrenaline (NA).
W, Maruyama, M, Naoi, H, Narabayashi
openaire   +1 more source

Droxidopa for the Treatment of Parkinson’s Disease

2020
Mizuki Ito, Hirohisa Watanabe
openaire   +1 more source

Droxidopa reduces postural sway in Parkinson disease patients with orthostatic hypotension.

Parkinsonism & Related Disorders, 2022
L. Marsili, K. Duque, Andrea Sturchio, G. Sobrero, I. Premoli, A. Dwivedi, A. Espay, A. Merola   +7 more
semanticscholar   +1 more source

Droxidopa management by an integrated health-system specialty pharmacy team.

Journal of the American Pharmacists Association, 2022
Sabrina Livezey, Nisha B. Shah, Joshua DeClercq, Jessica Keefe, L. Choi, C. Shibao, A. Zuckerman   +6 more
semanticscholar   +1 more source

Rescue Therapy for an Old Challenging Problem: Droxidopa in the Management of Intradialytic Hypotension

Journal of the American Society of Nephrology, 2022
Lakshna Sankar, Kartik Kalra
semanticscholar   +1 more source

Stabilisiert Droxidopa den Blutdruck?

InFo Neurologie & Psychiatrie, 2014
openaire   +2 more sources

Droxidopa

2023
Jose-Alberto Palma, Horacio Kaufmann
openaire   +1 more source

CLINICAL USE PATTERNS AND SAFETY PROFILE OF DROXIDOPA FOR INTRAVENOUS VASOPRESSOR WEANING IN SEPTIC SHOCK

Chest
Daniel Ying, Parth Pancholi, Rohit S Munagala, P. Sathe, Jack Jnani, Keith Falsetta, Evelyn Luo, Krislyn Schweiger, Paul H Mayo, Kelvin Wong, M. Narasimhan   +10 more
semanticscholar   +1 more source

Amantadine/droxidopa interaction

Reactions weekly

semanticscholar   +1 more source